Tag: Pharmaceutical industry

Europe says No to drug data access ” arguing that this would undermine commercial interests and that there was no overriding public interest in disclosure”

Public release date: 10-May-2011 – Request Repost Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather than the lives and welfare of patients by withholding unpublished trial data, argue researchers on […]

Are you Big Pharma’s new target market?

  Taking a cue from Apple and Coca-Cola, pharmaceutical firms are humanizing their brands       Version française Montreal, February 4, 2014 — By 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3 trillion USD. To corner their share of profits, […]

FDA – 2012 law now in effect which lifts conflict of interest restrictions on FDA advisory panels

Contact: Kathy Fackelmann kfackelmann@gwu.edu 202-994-8354 George Washington University School of Public Health and Health Services Conflict-of-interest restrictions needed to ensure strong FDA review Panel members with ties to industry might lead to approval of unsafe drugs, new analysis suggests WASHINGTON, DC—A 2012 law that loosened conflict-of-interest restrictions for […]

‘Medical stocks are down by 90 percent’: Greece accuses pharma giants of slashing imports

Published time: February 28, 2013 01:36                                                                             AFP Photo / Louisa Gouliamaki The Greek government has reportedly accused 50 leading pharmaceutical companies of cutting off supplies of key medications to the country, sparking a run on pharmacies. Drug companies say the cheap medicines they supply merely get re-exported […]

Study finds that ‘Big Pharma’ fails at self-policing ED drug advertising: Sex, lies and television?

“The mechanism set up by PhRMA for consumers to make complaints does not function: the FAX machine is typically not connected and complaints go unanswered.”   Contact: Buffie Stephens buffiestephens@uncc.edu 704-687-5830 University of North Carolina at Charlotte CHARLOTTE, N.C. –Feb. 14, 2013– The pharmaceutical industry’s efforts to self-regulate […]

Drugs giant Novartis warns jobs may go overseas: said bringing a drug to an NHS trust, securing clinical trials and getting approval, is inefficient and takes too long

The Government must tackle the red-tape and research hold-ups hampering Britain’s pharmaceutical industry or risk seeing jobs and investment disappear overseas, one of the industry’s leading companies has warned. Novartis global finance director Jon Symonds said that while the UK has made “great strides” in supporting life sciences, […]

Osteoporosis Drugs, Reduce Fracture Risk by ONLY 0.9% according to studies

Contact: Emma Dickinson edickinson@bmj.com 44-020-738-36529 BMJ-British Medical Journal Value of drugs for pre-osteoporosis exaggerated Drugs for pre-osteoporosis: Prevention or disease-mongering? Public release date: 17-Jan-2008 A series of recent scientific publications have exaggerated the benefits and underplayed the harms of drugs to treat pre-osteoporosis or “osteopenia” potentially encouraging treatment […]

Drugs companies ‘are putting profits ahead of medical discoveries’, claims hard-hitting report

For every £1 spent on basic research a  whopping £19 is spent on marketing, claim experts Current reward system discourages  innovation, they add  By Claire Bates PUBLISHED:10:13 EST, 8  August 2012| UPDATED:11:08 EST, 8 August 2012 Read more: http://www.dailymail.co.uk/health/article-2185437/Drugs-companies-putting-profits-ahead-medical-discoveries.html#ixzz23E8u5ocy The pharmaceutical industry is in crisis  because companies are […]